Literature DB >> 11072266

Neuroimaging in dementia.

W J Jagust1.   

Abstract

Positron emission tomography, single photon emission computed tomography, and MR imaging are brain imaging techniques that have been applied widely to the study of patients with dementia. This article reviews current data on the clinical use of these techniques in the differential diagnosis of dementia and the prediction of dementia in those at risk.

Entities:  

Mesh：

Year:  2000        PMID： 11072266     DOI： 10.1016/s0733-8619(05)70231-0

Source DB:  PubMed          Journal:  Neurol Clin        ISSN： 0733-8619            Impact factor:   3.806


  10 in total

1.  Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.

Authors:  Y Zhang; N Schuff; G-H Jahng; W Bayne; S Mori; L Schad; S Mueller; A-T Du; J H Kramer; K Yaffe; H Chui; W J Jagust; B L Miller; M W Weiner
Journal:  Neurology       Date:  2007-01-02       Impact factor: 9.910

2.  Identification of Alzheimer's disease-associated rare coding variants in the ECE2 gene.

Authors:  Xinxin Liao; Fang Cai; Zhanfang Sun; Yun Zhang; Juelu Wang; Bin Jiao; Jifeng Guo; Jinchen Li; Xixi Liu; Lina Guo; Yafang Zhou; Junling Wang; Xinxiang Yan; Hong Jiang; Kun Xia; Jiada Li; Beisha Tang; Lu Shen; Weihong Song
Journal:  JCI Insight       Date:  2020-02-27

3.  Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.

Authors:  W Staffen; U Schönauer; H Zauner; I Spindler; A Mair; B Iglseder; G Bernroider; G Ladurner
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

4.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Authors:  Nathan A Johnson; Geon-Ho Jahng; Michael W Weiner; Bruce L Miller; Helena C Chui; William J Jagust; Maria L Gorno-Tempini; Norbert Schuff
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

Review 5.  Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.

Authors:  Bradford C Dickerson; Reisa A Sperling
Journal:  NeuroRx       Date:  2005-04

6.  Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer's type: a semiquantitative and automated evaluation.

Authors:  W Staffen; J Bergmann; U Schönauer; H Zauner; M Kronbichler; S Golaszewski; G Ladurner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-10       Impact factor: 9.236

7.  Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease.

Authors:  C A Raji; C Lee; O L Lopez; J Tsay; J F Boardman; E D Schwartz; W S Bartynski; H M Hefzy; H M Gach; W Dai; J T Becker
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

8.  Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta.

Authors:  Jennifer C Palmer; Shabnam Baig; Patrick G Kehoe; Seth Love
Journal:  Am J Pathol       Date:  2009-06-18       Impact factor: 4.307

9.  Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment.

Authors:  Anna Zimny; Joanna Bladowska; Małgorzata Neska; Kamila Petryszyn; Maciej Guziński; Paweł Szewczyk; Jerzy Leszek; Marek Sąsiadek
Journal:  Med Sci Monit       Date:  2013-02-04

Review 10.  Vascular dementia: Diagnostic criteria and supplementary exams. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part I.

Authors:  Eliasz Engelhardt; Carla Tocquer; Charles André; Denise Madeira Moreira; Ivan Hideyo Okamoto; José Luiz de Sá Cavalcanti
Journal:  Dement Neuropsychol       Date:  2011 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.